Intra-Cellular Therapies Inc

Lupin Pharmaceuticals specializes in the design and development of a variety of generic medicines. Operational since 2003, the company s facilities are approved by the Food and Drug Administration. It develops and markets a range of drugs for children under the Suprax brand. The company maintains more than 10 manufacturing facilities in the United States. Lupin Pharmaceuticals is a wholly owned subsidiary of Lupin Limited, which is one of the leading pharmaceutical companies in India. With annual revenues of over $690 million, Lupin Limited maintains a research and development center in Pune in India. The company specializes in the development of drugs for the treatment of diabetes.

Marine Enterprises International, based in Essex, MD, has been a trusted provider of Crystal Sea Marinemix, the leading artificial seawater mix in the aquatics industry, for over 50 years. Their single-stage, homogeneous blend accurately duplicates natural seawater, allowing marine animals of all kinds to thrive, including delicate cephalopods, corals, and sargassum seahorses. With a strong focus on customer service, Marine Enterprises works closely with clients in the commercial aquatics industry, including public aquariums, seafood holding systems, aquaculture and research facilities, zoos, and tropical fish wholesalers, to ensure they receive the high-quality product they need, when they need it. Testimonials from satisfied customers highlight the superior quality of Crystal Sea Marinemix and the exceptional customer service provided by Marine Enterprises International.Generated from the website

Emergent BioSolutions is a biopharmaceutical company headquartered in Rockville, Md. It develops, manufactures and commercializes a range of immunobiotics, including vaccines and therapeutics. Its BioThrax vaccine, approved by the Food and Drug Administration, is used for the prevention of anthrax infection. The company s commercial business focuses on immunobiotics that are used against infectious diseases and other medical conditions. Its commercial portfolio includes vaccines for hepatitis, meningitis and typhoid disorders. Emergent BioSolutions operates various offices in Singapore, Germany and the United Kingdom. It also maintains a network of third-party marketing representatives in the Middle East, Turkey, India, Australia and several Scandinavian countries in Europe.